This site is intended for Healthcare Professionals only.

Tag: National Institute for Health and Care Excellence (NICE)

spot_imgspot_img

Community pharmacies to provide free COVID-19 tests to eligible patients

The new Advanced service to supply Lateral Flow Device (LFD) kits through pharmacists is set to launch next month The Department of Health and Social...

NICE recommends new treatment for urothelial cancer

The National Institute for Health and Care Excellence (NICE) has recommended a new treatment, ‘avelumab’, for metastatic urothelial cancer. The recommendation follows a successful appeal...

NICE recommends Forxiga to treat chronic kidney disease

The National Institute for Health and Care Excellence (NICE) today issued a draft guidance recommending dapagliflozin, sold under the brand name Forxiga among others,...

NICE announces roundtable to discuss myalgic encephalomyelitis

After the pause to the publication of the guideline about myalgic encephalomyelitis (also known as chronic fatigue syndrome), the National Institute for Health and...

NICE recommends new ‘cost-effective’ migraine drug

National Institute for Health and Care Excellence (NICE) today recommended Teva’s migraine drug fremanezumab, sold under the brand name Ajovy, for NHS use. The final...